<- Go Home

Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.

Market Cap

SEK 1.1B

Volume

28.9K

Cash and Equivalents

SEK 75.3M

EBITDA

SEK 43.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

SEK 206.7M

Profit Margin

80.27%

52 Week High

SEK 159.60

52 Week Low

SEK 57.80

Dividend

N/A

Price / Book Value

2.93

Price / Earnings

70.41

Price / Tangible Book Value

3.06

Enterprise Value

SEK 1.0B

Enterprise Value / EBITDA

18.35

Operating Income

SEK 34.8M

Return on Equity

4.36%

Return on Assets

4.71

Cash and Short Term Investments

SEK 75.3M

Debt

SEK 49.0M

Equity

SEK 357.9M

Revenue

SEK 257.5M

Unlevered FCF

-SEK 35.0M

Sector

Biotechnology

Category

N/A

Company Stock Pitches